Deutsche Bank Aktiengesellschaft Raises Avantor (NYSE:AVTR) Price Target to $25.00

Avantor (NYSE:AVTR) had its price target raised by Deutsche Bank Aktiengesellschaft from $23.00 to $25.00 in a research note published on Thursday, Benzinga reports. Deutsche Bank Aktiengesellschaft currently has a hold rating on the stock.

A number of other research analysts have also weighed in on the company. Raymond James lifted their target price on Avantor from $22.50 to $26.00 and gave the company an outperform rating in a report on Friday, January 26th. Royal Bank of Canada boosted their price objective on shares of Avantor from $28.00 to $29.00 and gave the company an outperform rating in a research note on Thursday, February 15th. Barclays increased their target price on shares of Avantor from $27.00 to $30.00 and gave the stock an overweight rating in a research note on Wednesday, April 10th. JPMorgan Chase & Co. boosted their price target on shares of Avantor from $26.00 to $29.00 and gave the company an overweight rating in a research report on Thursday, February 15th. Finally, Citigroup increased their price objective on Avantor from $24.00 to $30.00 and gave the stock a buy rating in a research report on Thursday, February 15th. Four investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of Moderate Buy and an average price target of $26.71.

Avantor Price Performance

AVTR opened at $24.10 on Thursday. The firm has a 50-day moving average price of $24.93 and a 200-day moving average price of $22.47. Avantor has a twelve month low of $16.63 and a twelve month high of $26.16. The company has a quick ratio of 1.05, a current ratio of 1.61 and a debt-to-equity ratio of 1.00. The company has a market capitalization of $16.35 billion, a price-to-earnings ratio of 50.21, a PEG ratio of 2.47 and a beta of 1.37.

Avantor (NYSE:AVTR) last released its quarterly earnings data on Wednesday, February 14th. The company reported $0.25 earnings per share for the quarter, beating analysts’ consensus estimates of $0.22 by $0.03. The business had revenue of $1.72 billion during the quarter, compared to analyst estimates of $1.70 billion. Avantor had a net margin of 4.61% and a return on equity of 14.11%. Avantor’s revenue was down 4.0% compared to the same quarter last year. During the same period in the previous year, the business earned $0.32 EPS. Equities analysts expect that Avantor will post 1.01 EPS for the current year.

Insiders Place Their Bets

In other news, EVP James Bramwell sold 6,203 shares of the stock in a transaction that occurred on Tuesday, February 27th. The shares were sold at an average price of $24.49, for a total value of $151,911.47. Following the transaction, the executive vice president now owns 101,143 shares in the company, valued at approximately $2,476,992.07. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 1.50% of the company’s stock.

Hedge Funds Weigh In On Avantor

Several institutional investors and hedge funds have recently bought and sold shares of AVTR. Fifth Third Bancorp increased its stake in shares of Avantor by 125.3% in the fourth quarter. Fifth Third Bancorp now owns 1,248 shares of the company’s stock worth $28,000 after purchasing an additional 694 shares in the last quarter. Livforsakringsbolaget Skandia Omsesidigt increased its stake in Avantor by 565.5% in the 4th quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,331 shares of the company’s stock worth $30,000 after buying an additional 1,131 shares in the last quarter. Quarry LP raised its holdings in Avantor by 815.3% during the first quarter. Quarry LP now owns 1,437 shares of the company’s stock valued at $30,000 after acquiring an additional 1,280 shares during the period. Gladius Capital Management LP purchased a new position in shares of Avantor in the fourth quarter valued at about $42,000. Finally, Montag A & Associates Inc. bought a new position in shares of Avantor in the fourth quarter worth about $43,000. 95.08% of the stock is currently owned by hedge funds and other institutional investors.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.